| Bioactivity | Anti-hepatic fibrosis agent 2 (Compound 6k) is an orally active COL1A1 inhibitor. Anti-hepatic fibrosis agent 2 is an anti-fibrogenic agent targeting ewing sarcoma breakpoint region 1 (EWSR1)[1]. |
| Name | Anti-hepatic fibrosis agent 2 |
| CAS | 2380421-60-1 |
| Formula | C26H41N3O |
| Molar Mass | 411.62 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bao Y, et al. Evolution and Discovery of Matrine Derivatives as a New Class of Anti-Hepatic Fibrosis Agents Targeting Ewing Sarcoma Breakpoint Region 1 (EWSR1). J Med Chem. 2023 Jun 22;66(12):7969-7987. |
Anti-hepatic fibrosis agent 2
CAS: 2380421-60-1 F: C26H41N3O W: 411.62
Anti-hepatic fibrosis agent 2 (Compound 6k) is an orally active COL1A1 inhibitor. Anti-hepatic fibrosis agent 2 is an an
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.